Merck Pays $23 Million to End Vioxx Drug-Purchase Suits

Merck & Co., which paid $4.85 billion to resolve lawsuits contending its Vioxx painkiller caused heart attacks, will pay another $23 million to settle claims it duped consumers into buying the drug.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.